- Home
- ORC vs PCRX Comparison
ORC vs PCRX Comparison
Compare ORC & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORC
- PCRX
- Stock Information
- Founded
- ORC 2010
- PCRX 2006
- Country
- ORC United States
- PCRX United States
- Employees
- ORC N/A
- PCRX N/A
- Industry
- ORC Real Estate Investment Trusts
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- ORC Real Estate
- PCRX Health Care
- Exchange
- ORC Nasdaq
- PCRX Nasdaq
- Market Cap
- ORC 623.6M
- PCRX 604.7M
- IPO Year
- ORC 2013
- PCRX 2011
- Fundamental
- Price
- ORC $7.93
- PCRX $24.52
- Analyst Decision
- ORC Buy
- PCRX Buy
- Analyst Count
- ORC 3
- PCRX 10
- Target Price
- ORC $9.50
- PCRX $27.60
- AVG Volume (30 Days)
- ORC 2.3M
- PCRX 741.3K
- Earning Date
- ORC 01-30-2025
- PCRX 02-27-2025
- Dividend Yield
- ORC 18.16%
- PCRX N/A
- EPS Growth
- ORC N/A
- PCRX N/A
- EPS
- ORC 1.01
- PCRX N/A
- Revenue
- ORC $75,695,000.00
- PCRX $694,957,000.00
- Revenue This Year
- ORC N/A
- PCRX $4.83
- Revenue Next Year
- ORC N/A
- PCRX $2.16
- P/E Ratio
- ORC $7.84
- PCRX N/A
- Revenue Growth
- ORC N/A
- PCRX 4.40
- 52 Week Low
- ORC $7.41
- PCRX $11.16
- 52 Week High
- ORC $9.08
- PCRX $34.01
- Technical
- Relative Strength Index (RSI)
- ORC 52.22
- PCRX 76.79
- Support Level
- ORC $7.90
- PCRX $18.18
- Resistance Level
- ORC $8.11
- PCRX $22.36
- Average True Range (ATR)
- ORC 0.13
- PCRX 1.28
- MACD
- ORC 0.02
- PCRX 0.39
- Stochastic Oscillator
- ORC 71.09
- PCRX 89.19
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc invests in residential mortgage-backed securities (RMBS) across the United States. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.